CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Cellavision AB Company Snapshot
Cellavision AB operates in the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellavision AB with three other companies in this sector in Sweden: Arcoma AB (2017 sales of 91.85 million Swedish Kronor [US$10.20 million] ), C-Rad AB (133.13 million Swedish Kronor [US$14.78 million] of which 100% was Positioning external sales), and Boule Diagnostics AB (427.79 million Swedish Kronor [US$47.50 million] of which 40% was Own Consumables).

Sales Analysis. Cellavision AB reported sales of SEK 309.31 million (US$34.35 million) for the year ending December of 2017. This represents an increase of 16.7% versus 2016, when the company's sales were SEK 265.04 million. Sales at Cellavision AB have increased during each of the previous five years (and since 2012, sales have increased a total of 82%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cellavision AB
  Stock Performance Chart for Cellavision AB
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 251.20
(Figures in Swedish Kronor)
1 Week -10.3%   13 Weeks -2.6%  
4 Weeks 0.5%   52 Weeks 78.2%  
 
Cellavision AB Key Data:
  Ticker: CEVI Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2017 Sales 309,312,000
(Year Ending Jan 2018).
Employees: 99
  Currency: Swedish Kronor Market Cap: 5,991,508,606
  Fiscal Yr Ends: December Shares Outstanding: 23,851,547
  Share Type: Aktie Closely Held Shares: 7,274,722
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.